The Goldman Sachs Group Initiates Coverage on Cochlear (OTCMKTS:CHEOY)

Analysts at The Goldman Sachs Group assumed coverage on shares of Cochlear (OTCMKTS:CHEOY) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage set a “neutral” rating on the stock.

Cochlear Stock Up 0.2 %

CHEOY opened at $94.31 on Thursday. Cochlear has a 12-month low of $89.39 and a 12-month high of $115.85. The firm’s fifty day moving average price is $94.82 and its 200 day moving average price is $99.71.

About Cochlear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.